Prof. Dr. Iris Löw-Friedrich Biography
Prof. Dr. Iris Löw-Friedrich
Prof. Iris Löw-Friedrich, M.D., Ph.D., has been a member of BioNTech’s Supervisory Board since 2026. From 2008 to 2024 she was Chief Medical Officer, Global Head of Development and member of the Executive Committee at UCB S.A.. Between 1996 and 2008, she held various leadership roles at Schwarz Pharma AG/UCB S.A., BASF Pharma, and HMR/Aventis. She currently serves on several supervisory boards in the healthcare industry, including Fresenius SE & Co. KGaA. Iris Löw-Friedrich studied medicine at the Goethe University in Frankfurt am Main and earned her doctorate in 1985 at the Max-Planck-Institute for Biophysics. Since 2000, she has been an adjunct professor of internal medicine.
- Member of the Compensation, Nominating and Corporate Governance Committee
- Member of the Product Committee
